Machine Solutions Buys Vante

Machine Solutions, which is backed by Forsyth Capital, has acquired Vante. Financial terms weren’t announced. The seller was Engineering & Research Associates. Tucson, Ariz.-based Vante designs, develops and manufactures process systems for the disposable medical device and biopharmaceutical industries.


FLAGSTAFF, AZ–(Marketwired – Sep 3, 2013) – Machine Solutions Inc. expands its presence in the medical device manufacturing equipment market with the announcement today that it has acquired Vante Inc., formerly privately owned through Engineering & Research Associates, Inc. Vante now becomes a part of Machine Solutions Inc.
A global leader in radiofrequency thermal forming equipment, Vante designs, develops and manufactures process systems for the disposable medical device and biopharmaceutical industries. Its headquarters are in Tucson, Arizona.
The acquisition aligns Machine Solutions’ major operational bases in Arizona and expands sales and distribution organizations throughout North America, Europe, Ireland and Asia. With 10,000+ machine installations, annual revenues approaching $35 million and more than 150 team members worldwide, the combined organizations bring their richness of culture and process automation experience to the interventional medical device industry.
“The addition of the Vante brand broadens our reach into the emerging space of medical device process automation and diversifies Machine Solutions Inc.’s market leadership position within our existing product lines,” stated Daniel Kasprzyk, CEO and president of Machine Solutions Inc. “This acquisition signals the initiation of a thoughtfully planned strategy for continued growth through our partnership with Forsyth Capital.” St. Louis-based hybrid equity investment firm Forsyth Capital acquired Machine Solutions Inc. in 2011.
“Vante is excited to be teaming up with Machine Solutions and to bring our combined customers around the world an even broader range of best of breed, cutting-edge products and services in the exciting and growing medical device field,” stated Vante’s new president, Brent Fausett. “Forsyth Capital has again demonstrated its visionary business acumen with this announcement and I see great things in our future.”
About Machine Solutions Inc.
Machine Solutions Inc. was founded with the mission of providing innovative and effective proprietary mechanical solutions to a variety of complex process, testing and device design challenges. MSI has been instrumental in automating manual processes within catheter and stent manufacturing operations and within the medical device industry. For more information, visit
About Vante Inc.
Vante is a global technology company that designs and produces products for the precise manipulation of medical plastics. The company serves more than 500 customers and works with more than 20 partners to distribute its products globally. Vante has been a leader in the medical device manufacturing industry since 1976. Specializing in the four categories of catheter manufacturing equipment, biopharmaceutical equipment, industrial applications and OEM solutions, Vante’s products include their own manufacturing systems, industrial tube sealers, and plastic sealing and welding technology. Vante’s dedicated research and development team designs all of its products and has been awarded more than 50 patents to date. For additional information, visit
About Forsyth Capital Investors, LLC
Forsyth Capital Investors is a St. Louis-based investment firm focused on making long-term investments in middle-market companies operating in the capital equipment and component manufacturing and insurance services sectors. Forsyth Capital’s investment approach offers a balanced blend of private equity fundamentals and significant operational expertise made possible by its strategic relationship with Barry-Wehmiller Group, Inc., a diversified capital equipment manufacturer. Because of its unique relationship with an active operating company, Forsyth Capital Investors offers many of the value-added resources of a strategic partner, while maintaining the entrepreneurial spirit and autonomy of the portfolio company’s leadership team. For more information, visit